David McIntosh: UK Plasma Action – a Founder’s Reflections
David McIntosh, Founder and Chair of United Plasma Action, shared a post on LinkedIn:
”UK Plasma Action – a Founder’s Reflections
The UKPA campaign, launched in June 2019, was aimed at the discontinuation of a 23 year-old ban on the pharmaceutical use of UK donors’ plasma.
Much has happened since then and much good work has been done. Our donations are once again contributing to the manufacture of some vital plasma-derived medicines. The worst of the waste has been halted.
However, it seems appropriate, seven years on, to pause and reflect on the progress made so far – and the extent to which more action is still required.
The 20th Century fears about alleged risks of Variant Creutzfeldt Jakob disease in this context have now finally been dispelled.
However, the full Regulatory consequences and Healthcare gains from this welcome development are yet to be realised.
There is unfinished business here…….”

Other posts featuring David McIntosh on Hemostasis Today.
-
Nov 8, 2026, 15:0310 Posts Not to Miss This Week
-
Nov 8, 2026, 14:55Andra T.: Antiphospholipid Syndrome and Its Thrombotic Risks
-
Nov 8, 2026, 14:06Shayan Mohammadmoradi: ZEUS Trial-Inflammation Reduction Without Fewer Cardiovascular Events
-
Nov 8, 2026, 14:05Kausik Ray: Plaque-Guided Care for Better Coronary Outcomes
-
Nov 8, 2026, 14:05Athira Elssa Johnson: Understanding Coronary Thrombosis and Its Risks
-
Nov 8, 2026, 14:04Sanjiv Beri: Blood Type Compatibility and the Balance of Giving and Receiving
-
Nov 8, 2026, 14:02Gabriela Hobbs: Recognizing Outstanding Abstract Achievements-ASH 2026
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics